# About Sermorelin Prescribed: An Independent Research Digest

> Sermorelin Prescribed is an independent editorial project that publishes plain-framed summaries of the peer-reviewed GHRH(1-29) research literature. Not a clinic, not a vendor.

An independent editorial reading of the GHRH(1-29) literature — what it is, and what it is not.

## What this site is

Sermorelin Prescribed is an independent editorial project that publishes summaries of the peer-reviewed research literature on sermorelin (GHRH(1-29)). We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

The site reads the literature through a single deliberate lens — safety and tolerability — because that is where the gap between public perception and published evidence is widest. We summarize what the studies measured, attribute every quantitative claim to its source, and mark plainly where the data are thin.

## What "prescribed" means here

The word "prescribed" in this site's name is editorial framing — a position this publisher occupies relative to the literature, not a claim about services we offer. We do not write prescriptions, take patients, or operate a pharmacy. We do not employ doctors, pharmacists, or any clinical team, and we do not offer treatment, consultation, or prescription services of any kind.

The distinction matters for sermorelin specifically, because its real history is easy to misstate. Sermorelin was a genuinely FDA-approved drug for pediatric growth-hormone deficiency, withdrawn from the US market in 2008 for commercial — not safety or efficacy — reasons, and is now prepared by compounding pharmacies. "Prescribed" here points at that documented regulatory story, read as editorial commentary, never at any service this site provides.

## How we handle the evidence

Every figure on this site is carried back to a named study, listed in full on the references page. Where a finding comes from a related GHRH analogue rather than from sermorelin itself — the body-composition and cognition numbers, for instance, which come from tesamorelin trials — we say so, rather than letting drug-class results stand in for sermorelin results.

We describe research findings only. We do not recommend doses for any person, we use studied-at-X framing for every figure, and we treat the limits of the literature as part of the record worth reporting. When authorities have judged a use unproven, we cite that judgment alongside the encouraging findings, not beneath them.

---

A frosted-glass reading of the sermorelin record — each GHRH(1-29) figure floated in its own panel and carried back to its study, the reported effects framed plainly beside where the long-term adult data genuinely thin, and the body-composition findings marked as tesamorelin where they belong; no clinic behind the glass and nothing here compounded, dosed, prescribed, or sold.